Detection and treatment of subclinical tuberculosis
File(s)1-s2.0-S1472979212001357-main.pdf (200.64 KB)
Published version
Author(s)
Type
Journal Article
Abstract
Reduction of active disease by preventive therapy has the potential to make an important contribution towards the goal of tuberculosis (TB) elimination. This report summarises discussions amongst a Working Group convened to consider areas of research that will be important in optimising the design and delivery of preventative therapies. The Working Group met in Cape Town on 26th February 2012, following presentation of results from the GC11 Grand Challenges in Global Health project to discover drugs for latent TB.
Date Issued
2012-07-21
Date Acceptance
2012-06-26
Citation
Tuberculosis, 2012, 92 (6), pp.447-452
ISSN
1873-281X
Publisher
Elsevier
Start Page
447
End Page
452
Journal / Book Title
Tuberculosis
Volume
92
Issue
6
Copyright Statement
Open access under CC BY-NC-ND license
Subjects
Science & Technology
Life Sciences & Biomedicine
Immunology
Microbiology
Respiratory System
IMMUNOLOGY
MICROBIOLOGY
RESPIRATORY SYSTEM
Detection
Treatment
Subclinical
Tuberculosis
NONREPLICATING MYCOBACTERIUM-TUBERCULOSIS
RANDOMIZED-TRIAL
SYSTEMS BIOLOGY
STRATEGIES
VACCINE
TB
PREVALENCE
INFECTION
THERAPY
Antitubercular Agents
Bacterial Load
Biomarkers
Drug Design
Female
Humans
Immunization Programs
Latent Tuberculosis
Male
Models, Animal
Mycobacterium tuberculosis
South Africa
Tuberculosis Vaccines
Biological Markers
11 Medical And Health Sciences
Publication Status
Published